147 related articles for article (PubMed ID: 6434315)
1. Endocrine effects of the combination of megestrol acetate and tamoxifen in the treatment of metastatic breast cancer.
Alexieva-Figusch J; Blankenstein MA; de Jong FH; Lamberts SW
Eur J Cancer Clin Oncol; 1984 Sep; 20(9):135-40. PubMed ID: 6434315
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects.
Alexieva-Figusch J; Blankenstein MA; Hop WC; Klijn JG; Lamberts SW; de Jong FH; Docter R; Adlercreutz H; van Gilse HA
Eur J Cancer Clin Oncol; 1984 Jan; 20(1):33-40. PubMed ID: 6363095
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of the effects of tamoxifen, megestrol acetate, or tamoxifen plus megestrol acetate on treatment response and survival in patients with metastatic breast cancer.
Gill PG; Gebski V; Snyder R; Burns I; Levi J; Byrne M; Coates A
Ann Oncol; 1993 Nov; 4(9):741-4. PubMed ID: 8280654
[TBL] [Abstract][Full Text] [Related]
4. Hormonal changes during a prolonged tamoxifen treatment in patients with advanced breast cancer.
Számel I; Vincze B; Hindy I; Hermann I; Borvendég J; Eckhardt S
Oncology; 1986; 43(1):7-11. PubMed ID: 3079899
[TBL] [Abstract][Full Text] [Related]
5. Hormonal effects of toremifene in breast cancer patients.
Számel I; Vincze B; Hindy I; Kerpel-Fronius S; Eckhardt S; Mäenpää J; Grönroos M; Kangas L; Sundquist H; Hajba A
J Steroid Biochem; 1990 Jun; 36(3):243-7. PubMed ID: 2142246
[TBL] [Abstract][Full Text] [Related]
6. Sex hormones in postmenopausal women with breast cancer on tamoxifen.
Kostoglou-Athanassiou I; Ntalles K; Gogas J; Markopoulos C; Alevizou-Terzaki V; Athanassiou P; Georgiou E; Proukakis C
Horm Res; 1997; 47(3):116-20. PubMed ID: 9050950
[TBL] [Abstract][Full Text] [Related]
7. Cyclic sequential endocrine therapy for advanced breast cancer using a combination of tamoxifen and megestrol acetate.
Crawford DJ; George WD; Smith DC; Stewart M; Paul J; Leake RE
Oncology; 1994 Oct; 51 Suppl 1():13-8. PubMed ID: 7970503
[TBL] [Abstract][Full Text] [Related]
8. Sequential treatment of metastatic breast cancer with tamoxifen after megestrol acetate therapy and vice versa (a retrospective study).
Alexieva-Figusch J; Van Putten WL; van Gilse HA; Blonk-vd Wijst J; Klijn JG
Med Oncol Tumor Pharmacother; 1985; 2(2):69-75. PubMed ID: 4058078
[TBL] [Abstract][Full Text] [Related]
9. Steroid sex hormones and prolactin in postmenopausal women with generalized mammary carcinoma during prolonged dexamethasone treatment.
Borkowski A; L'hermite M; Dor P; Longeval E; Rozencweig M; Muquardt C; Van Cauter E
J Endocrinol; 1977 May; 73(2):235-46. PubMed ID: 140915
[TBL] [Abstract][Full Text] [Related]
10. Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.
Ellmén J; Hakulinen P; Partanen A; Hayes DF
Breast Cancer Res Treat; 2003 Nov; 82(2):103-11. PubMed ID: 14692654
[TBL] [Abstract][Full Text] [Related]
11. Megestrol acetate in advanced breast carcinoma after failure to tamoxifen and/or aminoglutethimide.
Brufman G; Isacson R; Haim N; Gez E; Sulkes A
Oncology; 1994; 51(3):258-61. PubMed ID: 8196908
[TBL] [Abstract][Full Text] [Related]
12. Megestrol acetate: first-line therapy for advanced breast cancer.
Johnson PA; Bonomi PD; Anderson KM; Wolter JM; Economou SG
Semin Oncol; 1986 Dec; 13(4 Suppl 4):15-9. PubMed ID: 3798124
[TBL] [Abstract][Full Text] [Related]
13. Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients.
Rose DP; Chlebowski RT; Connolly JM; Jones LA; Wynder EL
Cancer Res; 1992 Oct; 52(19):5386-90. PubMed ID: 1394142
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen and megestrol acetate for postmenopausal breast cancer: diverging effects on liver proteins, androgens, and glucocorticoids.
Löfgren L; Wallberg B; Wilking N; Fornander T; Rutqvist LE; Carlström K; von Schoultz B; von Schoultz E
Med Oncol; 2004; 21(4):309-18. PubMed ID: 15579914
[TBL] [Abstract][Full Text] [Related]
15. Influence of progestins on serum hormone levels in postmenopausal women with advanced breast cancer--II. A differential effect of megestrol acetate and medroxyprogesterone acetate on serum estrone sulfate and sex hormone binding globulin.
Lundgren S; Lønning PE
J Steroid Biochem; 1990 Jun; 36(1-2):105-9. PubMed ID: 2141886
[TBL] [Abstract][Full Text] [Related]
16. LHRH-agonist treatment in clinical and experimental human breast cancer.
Klijn JG; de Jong FH; Lamberts SW; Blankenstein MA
J Steroid Biochem; 1985 Nov; 23(5B):867-73. PubMed ID: 3935869
[TBL] [Abstract][Full Text] [Related]
17. Endocrine effects of adjuvant chemotherapy and long-term tamoxifen administration on node-positive patients with breast cancer.
Jordan VC; Fritz NF; Tormey DC
Cancer Res; 1987 Jan; 47(2):624-30. PubMed ID: 3098415
[TBL] [Abstract][Full Text] [Related]
18. Changes in serum sex steroid levels during megestrol acetate therapy.
Pommier RF; Woltering EA; Fletcher WS
Surg Oncol; 1994 Dec; 3(6):351-9. PubMed ID: 7773452
[TBL] [Abstract][Full Text] [Related]
19. Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.
Palatsi R; Reinilä M; Kivinén S
Acta Derm Venereol; 1986; 66(3):225-30. PubMed ID: 2426899
[TBL] [Abstract][Full Text] [Related]
20. Megestrol acetate v tamoxifen in advanced breast cancer in postmenopausal patients.
Morgan LR
Semin Oncol; 1985 Mar; 12(1 Suppl 1):43-7. PubMed ID: 3975652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
